학술논문
Use of rilpivirine in HIV-1-infected individuals in routine clinical practice from 2012 to 2017 in France
Document Type
Article
Author
Potard, V.; Costagliola, D.; Gallien, S.; Canestri, A.; Abel, S.; Abgrall, S.; Allavena, C.; Bazus, H.; Becker, A.; François, B.; Bouvet De La Maisonneuve, P.; Bregigeon, S.; Brugnon, A.; Caby, F.; Calin, R.; Cheret, A.; Costagliola, D.; Truchis, P.D.; Denis, B.; Duvivier, C.; Enel, P.; Fischer, H.; Ghosn, J.; Goussef, M.; Grabar, S.; Huber, F.; Jacomet, C.; Joly, V.; Katlama, C.; Khuong, M.A.; Makinson, A.; Marchand, L.; Martin-Blondel, G.; Matheron, S.; Meynard, J.L.; Miailhes, P.; Nacher, M.; Piet, E.; Piroth, L.; Ploquin, M.; Rabier, V.; Robineau, O.; Rouveix Nordon, E.; Tattevin, P.
Source
In: Journal of Antimicrobial Chemotherapy . (Journal of Antimicrobial Chemotherapy, 1 February 2021, 76(2):467-476)
Subject
Language
English
ISSN
14602091
03057453
03057453